Clinical Trials Logo
  1. Home
  2. Morphine
  3. NCT03425084

Genetic Variation in Organic Cation Transport 1 (OCT1) and Its Significance for Morphine Pharmacokinetics

Morphine Clinical Trial

Official title:
Genetic Variation in Organic Cation Transport 1 (OCT1) and Its Significance for Morphine Pharmacokinetics

Clinical Trial Summary

The main objective of the trial is to investigate the effect of known genetic variants in organic cation transporter 1 (OCT1) on the effect of morphine after major surgery

Clinical Trial Description

The purpose of the experiment is to investigate the effect of known genetic variants in organic cation transporter 1 (OCT1) on the effect of morphine after major surgery. This is primarily done by investigating systemic exposure of morphine in a cohort of patients undergoing scheduled laparoscopic colon or laparoscopic rectum surgery, and as pain treatment with intravenous (iv) morphine at the end of and after surgery (primary endpoints). As a secondary endpoint, we will investigate the effect (pharmacodynamics) of morphine in the same patients by registering pain during rest and activity, side effects and the degree of sedation at appropriate time intervals. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03425084
Study type Interventional
Source University of Southern Denmark
Contact
Status Completed
Phase Phase 1
Start date June 1, 2018
Completion date February 7, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT02924974 - Spinal Morphine in Robotic Assisted Radical Prostatectomy Phase 4
Recruiting NCT03257319 - Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department Phase 3
Completed NCT04473508 - Erectus Nerve Block for Lumbar Spine Surgery Phase 3
Completed NCT02942550 - Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients Phase 4
Completed NCT01097148 - Peri -and Postoperative Drug Therapy Schedules for Morbidly Obese Patients Phase 4
Completed NCT04369950 - Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine Phase 4
Not yet recruiting NCT05843344 - Dexmedetomidine and Morphine as Adjuvants to US Guided Erector Spinae Plane Blocks in Elective Thoracic Surgeries N/A
Completed NCT03231683 - Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy Phase 2
Completed NCT05654363 - Observational Retrospective Study on Spinal Analgesia in Laparoscopic and Laparotomic Hysterectomy
Completed NCT01235637 - Alfentanil Versus Sufentanil for Pain in Children During for Tracheal Suction Phase 3
Completed NCT04672382 - Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine N/A
Terminated NCT03846102 - MORphine Use in the Fascia Iliaca Compartment Block With UltraSound Phase 4
Completed NCT02622022 - Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease Phase 4
Completed NCT04115462 - A Relation of Morphine-induced Itch and Pain Processing N/A
Withdrawn NCT04397458 - Rescue Quadratus Lumborum Blocks for Post-cesarean Pain Phase 4
Not yet recruiting NCT06182111 - Intraoperative Administration of Intravenous Morphine in Patients Undergoing Laparoscopic Cholecystectomy
Recruiting NCT05688371 - Dexmedetomidine Plus Low Dose Morphine Versus Standard Dose of Morphine in PCA in Children . N/A
Terminated NCT03948464 - Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder Phase 3
Completed NCT02067338 - Epidural Low Dose Morphine in Postoperative Pain After Posterior Lumbar Spinal Surgery Phase 4
Completed NCT06010056 - PCA Ketamine-Morphine VS PCA Morphine as Post-Operative Analgesia in Colorectal Surgery. Phase 4